PURPOSE: To present the evidence concerning the in¯uence of physical activity on the dyslipidaemia of obesity and overweight. METHODS: Review of a personal library of literature on the interactions of physical activity, lipoprotein metabolism and body fatness. SUMMARY OF FINDINGS: Obesity, in particular abdominal obesity, is associated with dyslipidaemia Ð speci®cally elevated plasma concentrations of triacylglycerol (TAG) in the fasted state, an exaggerated postprandial rise in plasma TAG, low concentrations of high density lipoprotein cholesterol (HDL) and possibly a preponderance of small dense low density lipoproteins. Regular physical activity contributes to the avoidance of overweight and hence to the development of dyslipidaemia. Although low levels of body fatness contribute to the high levels of HDL cholesterol and the low levels of TAG in trained people there are other important determinants of these characteristics. In particular, exercise (and probably training, that is regular, frequent exercise over months and years) enhances the metabolic capacity for TAG, possibly through mechanisms involving increased activity of lipoprotein lipase. This, in turn, has effects on other lipoprotein species such that the transport of TAG and cholesterol in the circulation is improved. There is evidence for a dose ± response relationship, with for example, higher levels of HDL cholesterol in men and women who expend more energy in exercise. For the majority of healthy, sedentary adults frequent, moderate intensity exercise equivalent to a total gross energy expenditure of about 8.5 MJ per week is probably a suf®cient to in¯uence lipoprotein lipids.
Introduction
Obesity has long been associated with dyslipidaemia and in particular with a cluster of metabolic disturbances which have been termed the metabolic syndrome or the insulin-resistance syndrome. The features of this syndrome as originally described are: resistance to insulin-stimulated glucose uptake, elevated plasma concentrations of triacylglycerol (TAG), low concentrations of high density lipoprotein (HDL) cholesterol and hypertension. 1 A number of other abnormalities, including high levels of apolipoprotein B, a preponderance of small dense low density lipoproteins (LDL), high levels of postprandial lipaemia, high levels of ®brinogen and plasminogen activator inhibitor I, are now known to be associated with the syndrome. 2, 3 The mechanisms which link overly high levels of body fat to dyslipidaemia are incompletely understood, but probably involve persistently elevated plasma concentrations of non-esteri®ed fatty acids (NEFA) attributable to an increased rate of lipolysis from the expanded adipose tissue mass. An increased¯u x of fatty acids to the liver leads to increased hepatic TAG synthesis and increased secretion of very low density lipoprotein (VLDL)-TAG. 4 Raised NEFA concentrations (within the physiological range) inhibit insulin-stimulated glucose uptake in a dosedependent manner, leading to peripheral insulin resistance. This is turn will exacerbate the dyslipidaemic state, through impairment of insulin's role in coordination of substrate metabolism, particularly during the postprandial period. Lipoprotein lipase (LPL), the enzyme responsible for the hydrolysis of lipoprotein TAG, is active in the capillary lumen of adipose tissue, skeletal and cardiac muscle. In insulinresistant states, the postprandial activation of adipose tissue LPL by insulin is impaired, reducing TAG clearance. Simultaneously, failure of the normal insulin-mediated suppression of NEFA release from adipose tissue maintains an inappropriately high postprandial concentration of fatty acids. This, in turn, leads to impairment of the normal postprandial suppression of VLDL secretion.
Both effects on TAG-rich lipoproteins (that is, impaired uptake and impaired suppression of secretion) lead to prolongation of their residence time in the circulation. This contributes to the development of dyslipidaemia through several mechanisms: the increased opportunity for exchange of core lipid with the cholesterol-rich lipoproteins leads to compositional changes in VLDL and probably eventually to a preponderance of small dense LDL. 5 Poor adipose tissue LPL activity may also lead to low concentrations of cholesterol in HDL; the action of LPL on TAG-rich lipoproteins leads to the dissociation of redundant surface components. Some of these, including free cholesterol, are transferred to HDL particles, resulting in the formation of stable, cholesterol esterrich HDL 2 particles. Poor TAG removal thus links hypertriglyceridaemia to low HDL cholesterol concentrations. Indeed, HDL cholesterol has been described as an`integrative marker' for TAG metabolic capacity. 6 The prevalence of the metabolic syndrome is particularly high for individuals with high levels of intraabdominal fat 7 and derangements to lipoprotein metabolism are exacerbated for a given level of obesity, when the intra-abdominal fat mass is enlarged (Table  1) . 8 One reason is probably that NEFA, mobilised from the omental and mesenteric depots are released directly into the portal vein, with increased hepatic uptake and the pathophysiological sequelae of this. This anatomical effect is reinforced by the fact that adipocytes from these depots are very sensitive to lipolytic stimuli 9 and at the same time relatively resistant to the anti-lipolytic effects of insulin. 10 They therefore make a very big contribution to the level of circulating NEFA. For a detailed discussion of the role of visceral fat in the dyslipidaemia of obesity the reader is referred elsewhere. 8 If the above rationale is sound, then losing body weight and fat may be expected to reduce plasma TAG concentrations and increase HDL cholesterol. There is evidence for this from both epidemiological and intervention studies. For example, a 12 y prospective study of men and women in Que Âbec, found increases in total body fatness were associated with deterioration in the plasma lipid pro®le. 11 Similarly, among Swiss men (two groups of former elite athletes and a control group of normal men), 15 y changes in anthropometric characteristics, especially abdominal fat, were related to plasma TAG concentrations and to the ratio (measured at the later time point) of cholesterol in LDL to that in HDL. 12 In the immediate post-weight loss period, plasma TAG has usually been reported to be reduced; 13 HDL cholesterol can be reduced immediately following weight loss, but is increased above pre-weight loss level if the weight loss is sustained over months. 13 Improvements in lipid pro®le may be particularly marked when the level of visceral fat is reduced. 13, 14 Effects of physical activity on lipoprotein metabolism
Intuitively, physical activity should contribute to the avoidance of overweight. Recent epidemiological studies have con®rmed this, showing that men and women who regularly engage in physical activity, experience a lower risk of clinically important weight gain over 10 y. 15, 16 In intervention studies, increased levels of physical activity tend to result in decreases in fatness, although these are invariably small Ð about 0.12 kg per week on average in men, a little less for women. 17 Thus, changes in lipoproteins associated with increased physical activity may be mediated, at least in part, through concomitant changes in body fat levels. Activity-induced alterations to lipoprotein concentrations, clearly are similar qualitatively to those achieved through weight loss: the consensus 18, 19 is that plasma TAG concentration is decreased, with increases in HDL cholesterol and decreases in LDL cholesterol and apolipoprotein B. Total plasma cholesterol concentration is not consistently reduced, relative to controls who remain sedentary. The marked differences in lipoprotein pro®le between endurance-trained and sedentary men and Physical activity, obesity and blood lipids AE Hardman women (Table 2) , thus probably re¯ect inevitable differences in body composition as well as differences in the level of regular physical activity. It is not possible therefore on the basis of such observations alone, to draw a conclusion concerning the mechanistic importance of exercise-induced decreases in body fatness. Indices re¯ecting energy expended in exercise have been related in cross-sectional studies to plasma lipoprotein concentrations, suggesting a role for the energy expenditure of exercise and (by inference) its effects on body fat stores. For example, among nearly 3000 men (70% of them military of®cers) who walked or jogged for exercise, there was a dose ± response relationship between mileage covered and HDL cholesterol concentration: this increased by about 0.008 mmol Á l 71 per mile through the range studied, that is, from 0 ± 31 miles Á week
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. 22 Thus, at a weekly exercise energy expenditure of about 7 MJ (1670 kcal), HDL cholesterol was 11% above the reference (sedentary) level. The inverse relation of mileage with plasma TAG levels was also linear. In the US National Runners' Health Study, running distance (proportional to energy expenditure) was the most important determinant of plasma HDL cholesterol level, with a six-fold more potent effect than running velocity. 23 Many intervention studies have reported exerciseinduced changes in lipoproteins, alongside changes in body weight or fatness (see for example Refs 24 ± 28). For instance, one study from the Stanford Heart Disease Prevention Program, 29 reported that 12 sedentary middle-aged men, with no speci®c instructions on dietary practices, lost an average of nearly 2 kg of body weight (nearly 2% of body mass) through following a modest one year programme of running; changes in percent body fat and in HDL cholesterol were related (r 0.47) and those men who averaged more than 12.9 km per week (8 miles) showed a signi®cant increase in HDL cholesterol and in HDL 2 mass. 29 The same group went on to carry out a randomised trial to compare in overweight men the effects of an energy de®cit created through increased physical activity (mainly walking and jogging) with a comparable energy de®cit achieved through dieting. 30 Weight loss, through diet or through exercise (3.5 ± 7.5 kg over a seven month period), was associated with increases of similar magnitude in HDL cholesterol and decreases in TAG. Recent studies have provided more detailed information on the qualitative basis of changes in lipoproteins with exercise and their relations with changes in adiposity. For example, 14 weeks of endurance training produced changes in the chemical composition of LDL (more cholesterolenriched and protein-poor), which were associated with reduced fat mass, umbilical girth and plasma TAG concentration. 31 In patients with well-controlled non-insulin-dependent diabetes mellitus (NIDDM), 14 a three-month exercise intervention (increasing physical activity by about 150 min Á week 71 ) resulted in a 20% decrease in TAG and a 23% increase in HDL cholesterol; no changes in body weight were discerned but body fatness decreased by b 3%, with a decrease in waist circumference, which might indicate a loss of visceral fat. 8 In overweight men with NIDDM, exercise-induced loss of body fat was signi®cantly associated with changes in fasting TAG concentrations and with the LDL cholesterolaHDL cholesterol ratio. 32 Several studies have speci®cally reported relationships of changes in visceral adipose tissue (or surrogate markers for this) with changes in plasma lipoproteins. Among obese women who trained for 14 months (®ve 90 min sessions of endurance exercise per week), both the decreases in plasma TAG and the increases in HDL cholesterol were proportional to losses of visceral adipose tissue and total fat. 33 These ®ndings contrast with the lack of a relationship between increases in maximal oxygen uptake (which can be presumed to re¯ect training intensity) and exercise-induced improvements (with regard to the risk of cardiovascular disease) in lipid pro®les. For example, in a study where the energy expenditure of each exercise regimen was the same, the speed of regular walking for exercise was unrelated to the ensuing increases in HDL cholesterol among sedentary women. 34 By contrast, the increase in maximal oxygen uptake was clearly related to the speed of walking.
On the other hand, not all intervention studies reporting changes in lipoprotein pro®le with exercise training have found that these were associated with decreases in body mass or indices of adiposity. For example, sedentary women who improved their ®tness through brisk walking (building up over three months to an average of nearly 30 min Á day
) showed a 27% increase increase in HDL cholesterol, 35 despite unchanged body weight and fatness, as determined by densitometry and anthropometry. 36 These women had rather low levels of HDL at baseline, however. Similar ®ndings have been reported for young men who showed a 14% increase in HDL cholesterol after six-months of endurance training, despite unchanged body weight and fatness. 37 An older group of men, studied alongside the younger men, experienced a small (approx. 2.5 kg) loss of weight and fat but the changes in HDL cholesterol and TAG were unrelated to changes in overall body fatness or in intra-abdominal fat measured by computed tomography (CT).
Meta-analysis of 95 studies on the in¯uence of exercise training on lipid and lipoprotein levels concluded that, although signi®cant changes in HDL cholesterol and in TAG were found for studies where body weight did not change, for both these variables the effect of exercise was heightened when body weight loss accompanied training. 38 The increase in HDL cholesterol averaged 3.3% (0.04 mmol Á l ), weight loss was prevented by increasing the energy intake to cover the energy cost of exercise (four 60 min sessions per week for one year). 39 Before and after training, the men were studied followed 18 days on a controlled diet. A 10% increase in HDL cholesterol was observed, which was associated with both increased HDL apolipoprotein A-I synthesis and decreased HDL protein catabolism; plasma TAG and apolipoprotein B decreased by 7% and 10%, respectively. Thus, weight loss is not necessary to increase HDL cholesterol Ð at least in overweight men.
Changes in lipoprotein metabolism independent of changes in body fatness
Besides decreases in the size of body fat stores, exercise has additional effects which modify lipoprotein metabolism. These may be largely in skeletal muscle, it may be postulated. It has been known for many years that training improves the microcirculation in skeletal muscle and the implications of this for the lipolytic action of LPL in this tissue have been elegantly demonstrated by a study using the one-leg training model; subjects trained one leg on a cycle ergometer over an eight-week period, permitting within-subject comparison between trained and untrained skeletal muscle of capillarisation and LPL activity. 40 Indices of capillarisation were related to LPL activity, which was signi®cantly greater in the trained muscle than in the untrained muscle.
Although research interest has focused on traininginduced increases in the activity of LPL, the possibility also exists that training increases muscle blood ow, facilitating TAG degradation by increasing the exposure of LPL to substrate. At least one study has reported higher muscle blood¯ow in endurance trained men, compared with inactive controls, 41 but the evidence is inconclusive.
Exercise and postprandial lipid and lipoprotein metabolism
If, as has been argued above, the main effects of exercise training on lipoprotein metabolism are mediated through an enhanced metabolic capacity for TAG, these may be most clearly evident during the postprandial state when the entry into the circulation of chylomicrons carrying exogenous TAG, increases the number of TAG-rich lipoproteins circulating. The level of the rise in plasma TAG concentration during the hours after a meal provides a functional measure of an individual's metabolic capacity for TAG. The reader will recall how this is likely, theoretically, to be impaired in insulin-resistant states, when the co-ordination of postprandial metabolism is disrupted. Repeated episodes of exaggerated postprandial lipaemia impair reverse cholesterol transport and increase the atherogenic stimulus. 42 The clinical relevance of this may be evident from recent case-control studies; postprandial plasma concentrations of TAG are strongly predictive of the presence or absence of CVD. 6, 43, 44 Thus, there is increasing research interest in the study of metabolic events during the postprandial period and of interventions, including exercise, which modify these.
Postprandial TAG responses re¯ect the fasting TAG pool size. 43 It might be expected, therefore, that obesity is associated with high postprandial, as well as fasting, TAG levels. There is recent evidence for this; greater 24 h postprandial response of plasma TAG has been reported in obese subjects (BMI approx. 44 kg Á m
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). 45 In line with the view that intra-abdominal adipose tissue mass is the most important determinant of the dyslipidaemia of obesity, Couillard et al 11 recently found that, when matched for fat mass, men with visceral obesity exhibited an exaggerated postprandial TAG response. This appeared to be explained mainly by higher postprandial VLDL production and the postprandial NEFA response was also elevated. 11 Thus levels of body fat, andaor the distribution of this, appear to be linked with functional measures of TAG metabolic capacity.
Individuals with habitually high levels of physical activity, such as trained athletes, exhibit low postprandial TAG responses. Postprandial lipaemia following an oral fat challenge is 27 ± 59% lower, 46 ± 49 and removal rates of intravenous TAG 26 ± 92% higher, 46,50 ± 53 in endurance-trained individuals (middle-aged men as well as young men and women) than in untrainedasedentary controls. In some of these studies, the athletic groups clearly possessed lower levels of body fat than the sedentary comparison groups; 47, 48, 52, 53 in others this was not reported but controls were not markedly different in body mass (information on fatness not reported). 46, 51 As well as differences in body fat levels, other factors such as habitual diet and muscle ®bre population probably contribute to the high metabolic capacity of athletes for TAG. Diet is probably not a major confounder, however, as athletes typically consume a greater proportion of energy from carbohydrate than the inactive controls. (High carbohydrate diets increase, rather than decrease, plasma TAG levels.) Muscle ®bre population characteristics might, however, contribute to low levels of lipaemia in athletes, because muscle LPL activity has been reported to be strongly related (r 0.95) to the proportion of type I (highly oxidative) ®bres in needle biopsy samples of human skeletal Physical activity, obesity and blood lipids AE Hardman muscle. 54 Type I ®bres typically comprise a majority of ®bres in successful endurance athetes. 55 Exercise intervention studies do not provide a clear picture of the role for decreased body mass or fat in changing postprandial lipaemia. In one careful study of six healthy men before and after seven weeks of jogging training, diet was carefully controlled to ensure that subjects did not lose body weight. 56 Despite this, chylomicron retinyl palmitate levels were reduced by 37% with training, indicative of enhanced chylomicron removal after training. A longer study, with 32 ± 48 weeks of training, found an increase (13%) in HDL cholesterol alongside a 49% improvement in the capability to clear an intravenous fat load. 57 Combining moderate restriction of energy intake with increased levels of physical activity (aerobic exercise plus light weight training) over 12 weeks, resulted in a reduction in the postprandial rise of plasma TAG, with a decrease of nearly three quarters in the chylomicron remnant concentration; 58 the overweight women in this study lost an average of 4.3 kg during this dual intervention. 58 On the other hand, two randomly controlled studies found no signi®cant improvement in fat tolerance with training, which resulted in loss of body fat. In one, men with primary hyperlipidaemia (n 17 type IV, high fasting TAG; n 6 type IIb, high total and low density lipoprotein cholesterol) were studied using an intravenous fat challenge. 59 Clearance rates for TAG did not differ, after training, from rates in controls, despite a loss of body fat (24.7% vs 25.6%). 59 In a more recent study, healthy middle-aged women (13 exercisers, 13 controls) trained over 12 weeks by brisk walking. 60 There were clear improvements in endurance ®tness and a decrease in the average sum of skinfold thicknesses (four standard sites) from 83.2 mm to 76.4 mm. Nevertheless, there was no change in the plasma TAG response to an oral fat load. One possibility is that the intensity of training, approximately 60% maximal aerobic ®tness (V Á O 2 max) was insuf®cient to stimulate morphological changes in skeletal muscle. It is noteworthy, however, that these two studies were speci®cally designed to exclude effects of recent exercise; subjects were studied between 48 ± 72 h after 59 and 48 h after 60 the last training session.
One way to examine the in¯uence of changes in training status in the absence of changes in body mass or fatness is to study a period of detraining in trained people. In endurance athletes, just 60 h without training resulted in an increase of more than one third in postprandial lipaemia, with a further (but much smaller) increase after a total of six days without training. 61 This ties in well with a rapid decrease in postheparin plasma LPL activity after only two days without training, in trained men and women. 62 On this evidence, the effects of a recent training session are probably subsumed within the measures of TAG capacity reported for endurance athletes in some studies. 46 Fasting TAG concentrations are reduced the day after prolonged exercise, alongside increases in LPL activity measured in post-heparin plasma. 63 It might be expected, therefore, that the plasma TAG response to dietary fat consumed the day after exercise would also be decreased and there is evidence for this. In one study, young adults walked for two hours at about 40% of V Á O 2 max one afternoon and their fat tolerance was tested the following morning, that is, about 18 h after the end of exercise. 64 Postprandial lipaemia (6 h area under the plasma TAG concentration vs time curve after a high-fat meal) was nearly one third lower than on a no-exercise control trial. One explanation maybeenhanceduptake ofTAGintothe previouslyexercised muscle. 65 Supporting, although indirect, evidence for this explanation comes from an examination of the effect of prior exercise on postprandial substrate metabolism in middle-aged women. When a high-fat mixed meal was ingested the morning after exercise, the women oxidized more fat postprandially than they did during a control trial, regardless of their training status. 66 It is not known, however, whether or not the recently ingested fat was the source of the additional fat oxidized.
There is evidence that energy expenditure per se is an important determinant of the exercise-induced decrease in postprandial lipaemia from a series of studies in the author's laboratory using the two-day model just described. Sessions of moderate or low intensity exercise, but of equivalent energy expenditure, that is, trading intensity for duration (1.5 h at 60% V Á O 2 max vs 3 h at 30% V Á O 2 max), resulted in identical decreases in lipaemia compared with a control (no-exercise) trial. 67 The pattern of exercise does not seem to in¯uence its effects on postprandial lipaemia, provided that suf®cient energy is expended; the reduction in lipaemia was similar after 90 min of moderate exercise performed in three separate 30 min sessions and after one continuous bout. 68 Nor does the relative importance of different metabolic substrates during a session of exercise appear to in¯uence its subsequent effects on postprandial lipaemia. We employed acipimox (an analogue of nicotinic acid) to prevent mobilisation of NEFA from adipose tissue, so that the contribution of carbohydrate to energy metabolism during exercise was increased, compared with a placebo trial. 69 Prior exercise reduced lipaemia, compared with a control (no-exercise) trial, irrespective of differences in substrate metabolism during exercise.
Collectively, these ®ndings suggest that the effect of a session of exercise on postprandial lipaemia is closely linked to energy expenditure, perhaps through some mechanism related to muscle contraction and mediated through changes in the expression of muscle proteins related to substrate acquisition in the exercised muscle. Even if muscle TAG is not degraded during exercise to provide fatty acids for beta oxidation, their oxidation during the post-exercise period must be enhanced if muscle glycogen concentration Physical activity, obesity and blood lipids AE Hardman
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was reduced by the exercise. Skeletal muscle LPL, like other proteins critical to the transport and metabolism of energy substrates for muscle, increases rapidly but transiently after exercise. 70 With the laboratory model described above, the effect of a single session of exercise on postprandial TAG metabolism may be partly attributable to the energy de®cit (relative to the control trial) because food intake was standardised during the day before the fat tolerance test, whether or not exercise was performed. We tested this hypothesis, creating a comparable de®cit by decreasing food intake by an amount equivalent to the net increase in energy expenditure by the exercise session. Restriction of energy intake did indeed reduce subsequent postprandial lipaemia, but the reduction attributable to the exercise session was signi®cantly greater. 71 Speculatively, the increased energy turnover associated with exercise may be important in maintaining a close coupling in skeletal muscle between energy expenditure and energy storage.
The effects of exercise and training on LPL activity, necessary responses to increased degradation of fat (and indirectly carbohydrate) substrates, are important determinants of the disposition of dietary lipids. Post-heparin plasma LPL activity has been reported to be higher in endurance-trained individuals than in inactive controls. 49, 53, 72 This probably mainly re¯ects increased activity in skeletal muscle. 40,73 ± 75 The effects of physical activity on adipose tissue LPL activity are complementary to those in skeletal muscle. A short period (5 ± 13 d) of exercise in sedentary people resulted in a 35% increase in LPL activity in muscle, with no change of activity in subcutaneous adipose tissue. 76 Low intensity training (50 ± 55% V Á O 2 max), more appropriate for individuals carrying excess weight, has also been reported to increase LPL in post-heparin LPL; 75 as adipose tissue LPL activity decreased, the inference must be that skeletal muscle LPL activity was enhanced by this exercise regimen.
In one of the few studies to measure parallel changes in muscle and adipose tissue, Simsolo et al 77 demonstrated the potential of activity-related changes in LPL to direct the storage of dietary lipids. They reported data for endurance athletes in the trained state and after two-weeks of detraining; LPL activity in muscle decreased markedly with detraining, alongside a clear increase in the activity of this enzyme in adipose tissue. 77 These ®ndings, and a recent report of an association between low skeletal muscle LPL activity and increased systemic respiratory quotient (hence reduced fat oxidation), 78 demonstrate the potential of exercise with the body's large muscles to in¯uence body composition in the longterm. This may be most dramatically demonstrated by comparison of responses to a high fat diet in mice; the profound increase in fat mass induced in normal animals by this diet was largely avoided in transgenic mice which over-expressed skeletal muscle LPL. 79 
Conclusion
The prevalence of the metabolic syndrome, in which abdominal obesity seems to play a determining role, is high in Western countries. For example, in one study only 36% of individuals were free of all six relevant measures (obesity, hypertension, hypertriglyceridaemia, glucose intolerance, hypercholesterolaemia and NIDDM). 80 Regular physical activity has the potential to help prevent overweight and obesity 15 and (by related as well as independent mechanisms) the associated dyslipidaemia. Associated bene®ts not touched on in this review include, improved insulin sensitivity, a reduced propensity to store fat in visceral depots and, speculatively, improved postabsorptive utilisation by muscle of NEFA. 81 Bearing in mind the links of multiple bene®ts with exercise energy expenditure and the rapid loss of these with exercise withdrawal, 61, 82 it is justi®ed to recommend exercise of moderate intensity on most days of the week with a total gross energy expenditure of some 2000 kcal (8.4 MJ) per week. Of course, this amount of exercise is not easy for the obese for whom even walking can represent vigorous exercise. 83 An intermittent exercise pattern is effective and may improve adherence in overweight persons. 84 The evidence of long-term adherence to increased physical activity levels among overweight and obese individuals is not promising, however, and the most important role for physical activity (in public health terms) may be in the avoidance of the dyslipidaemia of obesity.
